A review of published literature reveals almost no direct information on cardiomyopathy in Parkinson's disease, CMT2A, or DOA (despite compelling evidence for skeletal muscle involvement in all three syndromes), and cardiac phenotypes have been described in mice lacking the causal genes for each of these neurodegenerative conditions. Here, MFN2 is linked to cardiomyopathy.